Middlefield Announces Increases to ETF Distribution Rates

CALGARY, March 19, 2019 /CNW/ - Middlefield Group, on behalf of Middlefield Healthcare & Life Sciences ETF ("Life Sciences") (TSX: LS) and Middlefield REIT INDEXPLUS ETF ("REIT INDEXPLUS") (TSX: IDR), is pleased to announce the following increases to the monthly distribution rates, which are primarily supported by dividend growth within the respective fund portfolios.

Pursuant to the increase from $0.04167 to $0.05, Life Sciences distributions for the second quarter of 2019 will be payable to unitholders as follows:

Pursuant to the increase from $0.065 to $0.075, REIT INDEXPLUS distributions for the second quarter of 2019 will be payable to unitholders as follows:

Middlefield Group

Formed in 1979, Middlefield creates and manages specialized investment products for individual and institutional investors and has assets under management of approximately $4 billion. Investment products include mutual funds, exchange-traded funds, closed-end funds, private and public resource funds, real estate funds and a venture capital fund.

This press release contains forward-looking information. The forward-looking information contained in this press release is based on historical information concerning distributions and dividends paid on the securities of issuers historically included in the portfolio of the Funds. Actual future results, including the amount of distributions paid by the Funds, may differ from the monthly distribution amount. Specifically, the income from which distributions are paid may vary significantly due to: changes in portfolio composition; changes in distributions and dividends paid by issuers of securities included in the Funds' portfolios from time to time; there being no assurance that those issuers will pay distributions or dividends on their securities; the declaration of distributions and dividends by issuers of securities included in the portfolio will generally depend upon various factors, including the financial condition of each issuer and general economic and stock market conditions; the level of borrowing by the Fund; and the uncertainty of realizing capital gains.  The risks, uncertainties and other factors that could influence actual results are described under "Risk Factors" in the Funds' prospectus and other documents filed by the Funds with the Canadian securities regulatory authorities. The forward-looking information contained in this press release constitutes the Funds current estimate, as of the date of this press release, with respect to the matters covered hereby. Investors and others should not assume that any forward-looking statement contained in this press release represents the Funds estimate as of any date other than the date of this press release.

SOURCE Middlefield Healthcare & Life Sciences ETF